For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Also known as fibrin glue or fibrin sealant, the majority of available formulations contain a mixture of pooled plasma-derived fibrinogen and the enzyme thrombin.
Scope of the Report:
This report focuses on the Fibrinogen Concentrate in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
- CSL Behring
- Johnson & Johnson (Ethicon)
- LFB Group
- ProFibrix BV (The Medicines Company)
- Shanghai RAAS
- Jiangxi Boya Bio-Pharmaceutical
- Hualan Biological Engineering
- Harbin Pacific Biopharmaceutical
- Shanghai XinXing Medical
Market Segment by Countries, covering
- United States
Market Segment by Type, covers
- Human Fibrinogen Concentrate
- Animal Fibrinogen Concentrate
Market Segment by Applications, can be divided into
- Congenital Fibrinogen Deficiency
- Surgical Procedures (Trauma Patients, Cardiovascular Surgery Patients, PPH Patients, Plastic Surgery Patients)
There are 15 Chapters to deeply display the North America Fibrinogen Concentrate market.
Chapter 1, to describe Fibrinogen Concentrate Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Fibrinogen Concentrate, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Fibrinogen Concentrate, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Fibrinogen Concentrate market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Fibrinogen Concentrate Research Findings and Conclusion, Appendix, methodology and data source